Results for “ ”

Entry Author Date Location
Histogen, Timber Pharma Plan Reverse Mergers to Join Public Markets 01/28/20 San Diego
BioIntelliSense Debuts “Sticker” Sensor to Capture Patient Data Remotely 01/28/20 Boulder/Denver
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
Life Sciences IPOs Target Collective Raise of More Than $600M This Week 01/27/20 National
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits 01/22/20 New York
CEOs of Women’s Health Companies Fight to Open Investment Floodgates 01/22/20 San Diego
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data 01/14/20 National
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Roche Pays $40M to Use Amunix Pharma’s Half-Life Extension Tech 01/13/20 National
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira 01/10/20 Indiana
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy 01/08/20 San Francisco
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic 01/07/20 Boston
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger 01/03/20 San Diego
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s 12/17/19 Boston
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning 12/12/19 National
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink 12/11/19 National
BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs 12/09/19 San Francisco
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption 12/04/19 Raleigh Durham
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI 12/03/19 San Diego
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal 12/03/19 San Francisco
Page 1 of 632 next page »